Annual report pursuant to Section 13 and 15(d)

Condensed Financial Statements of Parent Company - Cash Flow Statement (Details)

v3.22.2.2
Condensed Financial Statements of Parent Company - Cash Flow Statement (Details) - USD ($)
$ in Thousands
 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities:      
Net income $ 21,376 $ 20,177 $ 40,297
Adjustments to reconcile net income to net cash (used in) provided by operating activities:      
Depreciation, depletion, accretion and amortization 65,730 49,806 39,301
Gain on sale of equipment (3,673) (2,043) (1,616)
Loss (gain) on derivative instruments (382) (3,209) 1,900
Equity-based compensation expense 8,000 3,549 1,570
Equity in net income of subsidiaries 21 (10) (603)
Deferred income tax benefit 5,966 3,745 3,310
Other non-cash adjustments 40 (46) (5)
Changes in operating assets and liabilities:      
Prepaid expenses and other current assets (4,912) (1,759) 8,103
Other assets (955) (2,928) 500
Accrued expenses and other current liabilities (11,559) 3,848 3,086
Net cash (used in) provided by operating activities 16,498 48,500 105,173
Cash flows from investing activities:      
Purchases of property, plant and equipment (68,851) (56,332) (52,574)
Proceeds from sale of equipment 7,525 3,654 3,041
Net cash used in investing activities (197,326) (263,412) (79,363)
Cash flows from financing activities:      
Principal payments on long-term debt (8,125) (95,350) (30,412)
Net cash provided by financing activities 159,136 123,847 41,887
Net change in cash, cash equivalents and restricted cash (21,692) (91,065) 67,697
Cash and cash equivalents:      
Beginning of year 57,251 148,316 80,619
End of year 35,559 57,251 148,316
Construction Partners Inc | Parent Company      
Cash flows from operating activities:      
Net income 21,376 20,177 40,297
Adjustments to reconcile net income to net cash (used in) provided by operating activities:      
Depreciation, depletion, accretion and amortization 757 475 463
Gain on sale of equipment (6) 0 0
Loss (gain) on derivative instruments (1,668) (894) 1,397
Equity-based compensation expense 8,000 3,549 1,570
Equity in net income of subsidiaries (24,690) (25,505) (43,712)
Deferred income tax benefit (248) (451) (425)
Other non-cash adjustments (73) 9 0
Changes in operating assets and liabilities:      
Prepaid expenses and other current assets (1,932) (135) (183)
Other assets (593) (2,008) (6)
Accrued expenses and other current liabilities 507 1,001 (965)
Other liabilities (748) (97) 0
Net cash (used in) provided by operating activities 682 (3,879) (1,564)
Cash flows from investing activities:      
Purchases of property, plant and equipment (243) (2,641) (1,189)
Proceeds from sale of equipment 6 0 0
Investment in subsidiary (10,986) 0 (17,303)
Net cash used in investing activities (11,223) (2,641) (18,492)
Cash flows from financing activities:      
Change in amounts due to (from) subsidiaries, net (65,622) (6,296) 34,150
Purchase of treasury stock (39) 0 0
Principal payments on long-term debt (420) 0 0
Proceeds from issuance of long-term debt, net of debt issuance costs and discount 54,527 0 0
Net cash provided by financing activities (11,554) (6,296) 34,150
Net change in cash, cash equivalents and restricted cash (22,095) (12,816) 14,094
Cash and cash equivalents:      
Beginning of year 65,225 78,041 63,947
End of year $ 43,130 $ 65,225 $ 78,041